GSK Plans Bioelectronic Implant Human Trials By 2017

British pharmaceutical company GlaxoSmithKline (GSK) is planning initial human trials for bioelectronic implants next year to advance a nascent field of research it helped pioneer, with hopes of making it a viable business alongside its struggling traditional drug offerings.

Source: Medical Design Online News - June 10, 2016 Category: Medical Equipment Source Type: news